Related references
Note: Only part of the references are listed.No muscle atrophy without GSK-3β. Focus on Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
Esther E. Dupont-Versteegden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression
Tadashi Yoshida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Signaling pathways perturbing muscle mass
David J. Glass
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Atrogin-1 Affects Muscle Protein Synthesis and Degradation When Energy Metabolism Is Impaired by the Antidiabetes Drug Berberine
Huiling Wang et al.
DIABETES (2010)
Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
Hanguo Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Mechanisms of Muscle Atrophy Induced by Glucocorticoids
O. Schakman et al.
HORMONE RESEARCH (2009)
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
Shenhav Cohen et al.
JOURNAL OF CELL BIOLOGY (2009)
Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
Julie Lagirand-Cantaloube et al.
PLOS ONE (2009)
The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
David S. Waddell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors
Sanjai Sharma et al.
BLOOD (2008)
The initiation factor eIF3-f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy
Julie Lagirand-Cantaloube et al.
EMBO JOURNAL (2008)
Contribution of Natural Inhibitors to the Understanding of the PI3K/PDK1/PKB Pathway in the Insulin-mediated Intracellular Signaling Cascade
Jae Youl Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Myofibrillar protein turnover: The proteasome and the calpains1,2
D. E. Goll et al.
JOURNAL OF ANIMAL SCIENCE (2008)
Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes
Michael Menconi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Mechanisms of glucocorticoid-induced myopathy
O. Schakman et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Glycogen synthase kinase 3β suppresses myogenic differentiation through negative regulation of NFATc3
Jos L. J. van der Velden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle
Brian A. Clarke et al.
CELL METABOLISM (2007)
Role of glucocorticoids in the molecular regulation of muscle wasting
Michael Menconi et al.
CRITICAL CARE MEDICINE (2007)
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease
Nicholas S. Hopkinson et al.
RESPIRATORY RESEARCH (2007)
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways
Eleonore Beurel et al.
PROGRESS IN NEUROBIOLOGY (2006)
Inhibition of glycogen synthase kinase-3β activity is sufficient to stimulate myogenic differentiation
JLJ van der Velden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells:: atrophy-inducible and atrophy-resistant C2C12 myotubes
KR Sultan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3β and PI3K/Akt/mTOR-dependent mechanisms
BG Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Skeletal muscle hypertrophy and atrophy signaling pathways
DJ Glass
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
GSK-3β inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes
AR Evenson et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor I and glycogen synthase kinase-3β inhibitors
CH Fang et al.
ENDOCRINOLOGY (2005)
Response of the ubiquitin-proteasome pathway to changes in muscle activity
MB Reid
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway
E Latres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
The molecular basis of skeletal muscle atrophy
RW Jackman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
IKKβ/NF-κB activation causes severe muscle wasting in mice
DS Cai et al.
CELL (2004)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1
JM Sacheck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
RS Jope
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle
CJ Wray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo
DB Ring et al.
DIABETES (2003)
Stable suppression of tumorigenicity by virus-mediated RNA interference
TR Brummelkamp et al.
CANCER CELL (2002)
GSK-3β negatively regulates skeletal myotube hypertrophy
DR Vyas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
C Rommel et al.
NATURE CELL BIOLOGY (2001)
Regulation of GSK-3: A cellular multiprocessor
AJ Harwood
CELL (2001)
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
RT Jagoe et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
WJ Ryves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation
PO Hasselgren et al.
ANNALS OF SURGERY (2001)
4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle
OJ Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
